Literature DB >> 22829014

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.

Stephanie Smetsers1, Joanne Muter, Claire Bristow, Leena Patel, Kate Chandler, Denise Bonney, Robert F Wynn, Anthony D Whetton, Andrew M Will, Davy Rockx, Hans Joenje, Gordon Strathdee, Jonathan Shanks, Eva Klopocki, Johan J P Gille, Josephine Dorsman, Stefan Meyer.   

Abstract

Fanconi anaemia (FA) is an inherited disease with congenital and developmental abnormalities characterised by cellular cross linker hypersensitivity. FA is caused by mutations in any of so far 15 identified FANC genes, which encode proteins that interact in a common DNA damage response (DDR) pathway. Individuals with FA have a high risk of developing acute myeloid leukaemia (AML) and squamous cell carcinoma. An increased cancer risk has been firmly established for carriers of mutations in FANCD1/BRCA2, FANCJ/BRIP1, FANCN/PALB2, RAD51C/FANCO and link the FA pathway to inherited breast and ovarian cancer. We describe a pedigree with FANCD2 mutations c.458T > C (p.Leu153Ser) and c.2715 + 1G > A (p.Glu906LeufsX4) with mild phenotype FA in the index case, T cell ALL in the Leu153Ser heterozygous brother and testicular seminoma in the p.Glu906LeufsX4 heterozygous father. Both FANCD2 alleles were present in the T Cell ALL and the seminoma. This links specific FANCD2 mutations to T cell ALL and seminoma without evidence of allelic loss in the tumour tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829014     DOI: 10.1007/s10689-012-9553-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  Genetic subtyping of Fanconi anemia by comprehensive mutation screening.

Authors:  Najim Ameziane; Abdellatif Errami; France Léveillé; Chantal Fontaine; Yne de Vries; Rosalina M L van Spaendonk; Johan P de Winter; Gerard Pals; Hans Joenje
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

2.  Mutations in BRIP1 confer high risk of ovarian cancer.

Authors:  Thorunn Rafnar; Daniel F Gudbjartsson; Patrick Sulem; Aslaug Jonasdottir; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Soren Besenbacher; Pär Lundin; Simon N Stacey; Julius Gudmundsson; Olafur T Magnusson; Louise le Roux; Gudbjorg Orlygsdottir; Hafdis T Helgadottir; Hrefna Johannsdottir; Arnaldur Gylfason; Laufey Tryggvadottir; Jon G Jonasson; Ana de Juan; Eugenia Ortega; Jose M Ramon-Cajal; Maria D García-Prats; Carlos Mayordomo; Angeles Panadero; Fernando Rivera; Katja K H Aben; Anne M van Altena; Leon F A G Massuger; Mervi Aavikko; Paula M Kujala; Synnöve Staff; Lauri A Aaltonen; Kristrun Olafsdottir; Johannes Bjornsson; Augustine Kong; Anna Salvarsdottir; Hafsteinn Saemundsson; Karl Olafsson; Kristrun R Benediktsdottir; Jeffrey Gulcher; Gisli Masson; Lambertus A Kiemeney; Jose I Mayordomo; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2011-10-02       Impact factor: 38.330

3.  Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arrays.

Authors:  Cynthia LeBron; Prodipto Pal; Mariana Brait; Santanu Dasgupta; Rafael Guerrero-Preston; Leendert H J Looijenga; Jeanne Kowalski; George Netto; Mohammad O Hoque
Journal:  Genomics       Date:  2011-03-02       Impact factor: 5.736

4.  Defective DNA double-strand break repair in pediatric systemic lupus erythematosus.

Authors:  Robert C Davies; Kelly Pettijohn; Francesca Fike; Jiexi Wang; Shareef A Nahas; Rashmi Tunuguntla; Hailiang Hu; Richard A Gatti; Deborah McCurdy
Journal:  Arthritis Rheum       Date:  2012-02

5.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

7.  FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia.

Authors:  Michael Hölzel; Paul J van Diest; Patrick Bier; Michael Wallisch; Maureen E Hoatlin; Hans Joenje; Johan P de Winter
Journal:  J Pathol       Date:  2003-10       Impact factor: 7.996

Review 8.  Fanconi anaemia and leukaemia - clinical and molecular aspects.

Authors:  Marc Tischkowitz; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

9.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

10.  A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.

Authors:  A Borriello; A Locasciulli; A M Bianco; M Criscuolo; V Conti; P Grammatico; S Cappellacci; A Zatterale; F Morgese; V Cucciolla; D Delia; F Della Ragione; A Savoia
Journal:  Leukemia       Date:  2006-11-09       Impact factor: 11.528

View more
  8 in total

1.  Molecular pathways: turning proteasomal protein degradation into a unique treatment approach.

Authors:  Sebastian Stintzing; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

2.  Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer.

Authors:  Yihang Shen; Jun Zhang; Herbert Yu; Peiwen Fei
Journal:  Cancer Cell Microenviron       Date:  2015-09-07

Review 3.  Update of the human and mouse Fanconi anemia genes.

Authors:  Hongbin Dong; Daniel W Nebert; Elspeth A Bruford; David C Thompson; Hans Joenje; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2015-11-24       Impact factor: 4.639

4.  Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.

Authors:  Stefan Meyer; Adam Stevens; Roberto Paredes; Marion Schneider; Michael J Walker; Andrew J K Williamson; Maria-Belen Gonzalez-Sanchez; Stephanie Smetsers; Vineet Dalal; Hsiang Ying Teng; Daniel J White; Sam Taylor; Joanne Muter; Andrew Pierce; Chiara de Leonibus; Davy A P Rockx; Martin A Rooimans; Elaine Spooncer; Stacey Stauffer; Kajal Biswas; Barbara Godthelp; Josephine Dorsman; Peter E Clayton; Shyam K Sharan; Anthony D Whetton
Journal:  Cell Death Dis       Date:  2017-06-15       Impact factor: 8.469

5.  Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Gayle P Pouliot; James Degar; Laura Hinze; Bose Kochupurakkal; Chau D Vo; Melissa A Burns; Lisa Moreau; Chirag Ganesa; Justine Roderick; Sofie Peirs; Bjorn Menten; Mignon L Loh; Stephen P Hunger; Lewis B Silverman; Marian H Harris; Kristen E Stevenson; David M Weinstock; Andrew P Weng; Pieter Van Vlierberghe; Alan D D'Andrea; Alejandro Gutierrez
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

6.  Novel diagnostic approaches for Fanconi anemia (FA) by single-cell sequencing and capillary nano-immunoassay.

Authors:  Lixian Chang; Xingjie Gao; Guangzhen Ji; Xuelian Cheng; Yao Zou; Tao Cheng; Weiping Yuan; Xiaofan Zhu
Journal:  Blood Sci       Date:  2021-01-21

Review 7.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

8.  Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients.

Authors:  Lixian Chang; Weiping Yuan; Huimin Zeng; Quanquan Zhou; Wei Wei; Jianfeng Zhou; Miaomiao Li; Xiaomin Wang; Mingjiang Xu; Fengchun Yang; Yungui Yang; Tao Cheng; Xiaofan Zhu
Journal:  BMC Med Genomics       Date:  2014-05-15       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.